Gastrointestinal transit and drug absorption

Pharmaceutical Dissolution Testing

Volumn , Issue , 2005, Pages 97-125

  Wilson, Clive G ^a   Kelly, Kilian ^a  

^a UNIVERSITY OF STRATHCLYDE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34848828888     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (67)

1. Washington N, Washington C, Wilson CG. Physiological Pharmaceutics:Barriers to Drug Absorption. Taylor & Francis, 2001.
2. Perkins AC, Wilson CG, Frier M, Blackshaw PE, Danserau RJ, Vincent RM, Wenderoth D, Hathaway S, Li Z, Spiller RC. The use of scintigraphy to demonstrate the rapid esophageal transit of the oval film-coated placebo risedronate tablet compared to a round uncoated placebo tablet when administered with minimal volumes of water. Int J Pharm 2001; 222:295-303.
3. Ekeberg O, Feinberg MJ. Altered swallowing function in elderly patients without dysphagia: radiological findings in 56 cases. Am J Roentgenol 1991; 156:1181-1184.
4. Perkins AC, Wilson CG, Frier M, Blackshaw PE, Juan D, Danserau RJ, Hathaways S, Li Z, Long P, Spiller RC. Oesophageal transit, disintegration and gastric emptying of a film-coated risedronate placebo tablet in gastro-oesophageal reflux disease and normal control subjects. Aliment Pharmacol Ther 2001; 15:115-121.
5. Perkins AC, Wilson CG, Blackshaw PE, Vincent RM, Danserau RJ, Juhlin KD, Bekker PJ, Spiller RC. Impaired oesophageal transit of capsule versus tablet formulations in the elderly. Gut 1994; 35:1363-1367.
6. Perkins AC, Wilson CG, Frier M, Vincent RM, Blackshaw PE, Danserau RJ, Juhlin KD, Bekker PJ, Spiller RC. Esophageal transit of risedronate cellulose-coated tablet and gelatin capsule formulations. Int J Pharm 1999; 186:169-175.
7. Hardy JG, Wilson CG. Radionuclide imaging in pharmaceutical, physiological and pharmacological research. Clin Phys Physiol Meas 1981; 2:71-121.
8. Wilson CG, Washington N. Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy. Drug Dev Ind Pharm 1988; 14:211-218.
9. Davis SS, Hardy JG, Taylor MJ, Whalley DR, Wilson CG. A comparative study of the gastrointestinal transit of a pellet and tablet formulation. Int J Pharm 1984; 21:167-177.
10. O’Reilly S, Wilson CG, Hardy JG. The influence of food on the gastric emptying of multiparticulate dosage forms. Int J Pharm 1987; 34:213-216.
11. Wilson CG, Washington N, Greaves JL, Kamali F, Rees JA, Sempik AK, Lampard JF. Bimodal release of ibuprofen in a sustained-release formulation-a scintigraphic and pharmacokinetic open study in healthy volunteers under different conditions of food-intake. Int J Pharm 1989; 50:155-161.
12. Collins PJ, Horowitz M, Maddox A, Myers JC, Chatterton BE. Effects of increasing solid component size of a mixed solid/liquid meal on solid and liquid gastric emptying. Am J Physiol 1996; 271:G549-G554.
13. Faas H, Steingoetter A, Feinle C, Rades T, Lengsfeld H, Boesiger P, Fried M, Schwizer W. Effects of meal consistency and ingested fluid volume on the intragastric distribution of a drug model in humans-a magnetic resonance imaging study. Aliment Pharmacol Ther 2002; 16:217-224.
14. Meyer JH, Lake R. Mismatch of duodenal deliveries of dietary fat and pancreatin from enterically coated microspheres. Pancreas 1997; 15:226-235.
15. Washington N, Moss HA, Washington C, Greaves JL, Steele RJC, Wilson CG. Non-invasive detection of gastro-oesophageal reflux using an ambulatory system. Gut 1993; 34:1482-1486.
16. Grattan T, Hickman R, Darby-Dowman A, Hayward M, Boyce M, Warrington S. A five way crossover human volunteer study to compare the pharmacokinetics of paracetamol following oral administration of two commercially available paracetamol tablets and three development tablets containing paracetamol in combination with sodium bicarbonate or calcium carbonate. Eur J Pharm Biopharm 2000; 49:225-229.
17. Rostami-Hodjegan A, Shiran MR, Ayesh R, Grattan TJ, Burnett I, Darby-Dowman A, Tucker GT. A new rapidly absorbed paracetamol tablet containing sodium bicarbonate. I. A four way crossover study to compare the concentration-time profile of paracetamol from the new paracetamol/sodium bicarbonate tablet and a conventional paracetamol tablet in fed and fasted volunteers. Drug Dev Ind Pharm 2002; 28:523-531.
18. Hunt JN, Pathak JD. The osmotic effects of some simple molecules and ions on gastric emptying. J Physiol 1960; 154:254-269.
19. Kelly K, O’ Mahony B, Lindsay B, Jones T, Grattan TJ, Rostami-Hodjegan A, Stevens HNE, Wilson CG. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulations, using Gamma scintigraphy. Pharm Res 2003; 20:1668-1673.
20. Hunt JN, Knox MT. A relation between the chain length of fatty acids and the slowing of gastric emptying. J Physiol 1968; 194:327-336.
21. Kumar D, Ritman EL, Malagelada JR. Three-dimensional imaging of the stomach: role of pylorus in the emptying of liquids. Am J Physiol 1987; 253:G79-G85.
22. Kleibeuker JHH, Beekhuis JNBJ, Jansen J, Piers DA, Lamers CBHW. Cholecystokinin is a physiological hormonal mediator of fat-induced inhibition of gastric emptying in man. Eur J Clin Invest 1988; 18:173-177.
23. Groning R, Heun G. Oral dosage forms with controlled gastrointestinal transit. Drug Dev Ind Pharm 1984; 10:527-539.
24. Groning R, Heun G. Dosage forms with controlled gastrointestinal passage-Studies on the absorption of nitrofurantoin. Int J Pharm 1989; 56:111-116.
25. Jamali F, Axelson JE. Influence of metoclopramide and propantheline on GI absorption of griseofulvin in rats. J Pharm Sci 1977; 66:1540-1543.
26. Marathe PH, Wen YD, Norton J, Greene DS, Barbhaiya RH, Wilding IR. Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br J Clin Pharmacol 2000; 50:325-332.
27. Read NW, McFarlane A, Kinsman RI, Bates TE, Blackhall NW, Farrar GBJ, Hall JC, Moss G, Morris AP, O’Neill B, Welch I, Lee Y, Bloom SR. Effect of infusion of nutrient solutions into the ileum on gastrointestinal transit and plasma levels of neurotensin and enteroglucagon. Gastroenterology 1984; 86:274-280.
28. Spiller R. The ileal brake-inhibition of jejunal motility after ileal fat perfusion in man. Gut 1984; 25:365-374.
29. Dobson CL, Davis SS, Chauhan S, Sparrow RA, Wilding IR. The effect of oleic acid on the human ileal brake and its implications for small intestinal transit of tablet formulations. Pharm Res 1999; 16:92-96.
30. Dobson CL, Davis SS, Chauhan S, Sparrow RA, Wilding IR. Does the site of intestinal delivery of oleic acid alter the ileal brake response?. Int J Pharm 2000; 195:63-70.
31. Lin HC, Van Citters GW, Heimer F, Bonorris G. Slowing of gastrointestinal transit by oleic acid. Dig Dis Sci 2001; 46:223-229.
32. Kaus LC, Fell JT, Sharma H, Taylor DC. The intestinal transit of a single non-disintegrating unit. Int J Pharm 1984; 20:315-323.
33. Von Schonfeld J, Evans DF, Renzing K, Castillo FD, Wingate DL. Human small bowel motor activity in response to liquid meals of different caloric value and different chemical composition. Dig Dis Sci 1998; 43:265-269.
34. Von Schonfeld J, Evans DF, Wingate DL. Effect of viscous fiber (guar) on postprandial motor activity in human small bowel. Dig Dis Sci 1997; 42:1613-1617.
35. Bryan AJ, Kaur R, Robinson G, Thomas NW, Wilson CG. Histological and physiological studies on the intestine of the rat exposed to solutions of Myrj 52 and PEG 2000. Int J Pharm 1980; 7:145-156.
36. Basit AW, Podczeck F, Newton JM, Waddington WA, Eli PJ, Lacey LF. Influence of polyethylene glycol on the gastrointestinal absorption of ranitidine. Pharm Res 2002; 19:1368-1374.
37. Bourquin LD, Titgemeyer EC, Fahey GC Jr. Vegetable fiber fermentation by human fecal bacteria: cell wall polysaccharide disappearance and short-chain fatty acid production during in vitro fermentation and water-holding capacity of unfermented residues. J Nutr 1993; 123:860-869.
38. Anti M, Pignataro G, Armuzzi A, Valenti A, Iascone E, Marmo R, Lamazza A, Pretaroli AR, Pace V, Leo F, Castelli A, Gasbarrini G. Water supplementation enhances the effect of high fiber diet on stool frequency and laxative consumption in adult patients with functional constipation. Hepatogastroenterology 1998; 45:727-732.
39. Goni I, Martin-Carron N. In vitro fermentation and hydration properties of commercial dietary fiber-rich supplements. Nutr Res 1998; 18:1077-1089.
40. Kendrick ML, Zyromski NJ, Tanaka T, Duenes DA, Libsch K, Sarr MG. Postprandial absorptive augmentation of water and electrolytes in the colon requires intraluminal glucose. J Gastrointest Surg 2002; 6:310-315.
41. Pimentel H, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome. Am J Gastroenterol 2000; 95:3503-3506.
42. Campbell JM, Fahey GC. Psylium and methylcellulose properties in relation to insoluble and soluble fiber standards. Nutr Res 1997; 17:619-629.
43. Tsukahara T, Azuma Y, Ushida K. The effect of a mixture of live lactic acid bacteria on intestinal gas production in pigs. Micr Ecol Health Dis 2001; 13:105-110.
44. Nobaek S, Johansson ML, Molin G, Ahrme S, Jeppson B. Alteration of intestinal microflora is associated with reduction abdominal bloating and pain in patients with irritbale bowel syndrome. Am J Gastroenterol 2000; 95:1231-1238.
45. Oufir LE, Barry JL, Flourie B, Cherbut C, Cloarec D, Bornet F, Galmiche JP. Relationships between transit time in man and in vitro fermentation of dietary fiber by fecal bacteria. Eur J Clin Nutr 2000; 54:603-609.
46. Watts PJ, Barrow L, Steed KP, Wilson CG, Spiller RC, Melia CD, Davies MC. The transit rate of different sized model dosage forms through the human colon and the effects of a lactulose- induced catharsis. Int J Pharm 1992; 87:215-221.
47. Lewis SJ, Heaton KW. Roughage revisited (the effect on intestinal function of inert plastic particles of different sizes and shapes). Dig Dis Sci 1999; 44:744-748.
48. Hebden JM, Perkins AC, Frier M, Wilson CG, Spiller RC. Limited exposure of left colon to daily dosed oral formulation in active distal ulcerative colitis: explanation of poor response to treatment?. Gut 1997; 40:28A.
49. Hardy JG, Wilson CG, Wood E. Drug delivery to the proximal colon. J Pharm Pharmacol 1985; 37:874-877.
50. Barrow L, Spiller RC, Wilson CG. Pathological influences on colonic motility: implications for drug delivery. Adv Drug Del Rev 1991; 7:201-218.
51. Stevens HNE, Wilson CG, Welling PG, Bakhshaee M, Binns JS, Perkins AC, Frier M, Blackshaw EP, Frame MW, Nichols JD, Humphrey MJ, Wicks SR. Evaluation of Pulsincap to provide regional delivery of dofetilide to the human GI tract. Int J Pharm 2002; 236:27-34.
52. Frexinos J, Bueno L, Fioramonti J. Diurnal changes in myoelectric spiking activity of the human colon. Gastroenterology 1985; 88:1104-1110.
53. Narducci FG, Basotti G, Gaburri M, Morelli A. Twenty four hour manometric recording of colonic motor activity in healthy man. Gut 1987; 28:17-25.
54. Soffer EE, Scalabrini P, Wingate D. Prolonged ambulant monitoring of human colonic motility. Am J Physiol 1989; 257:G601-G606.
55. Basotti G, Betti C, Imbimbo BP, Pelli MA, Morelli A. Colonic high-amplitude propogated contractions (mass movements):repeated 24 h manometric studies in healthy volunteers. J Gastrointest Mot 1992; 4:187-191.
56. Goo RH, Moore JG, Greenberg E, Alazraki NP. Circadian variation in gastric emptying of meals in humans. Gastroenterology 1987; 93:515-518.
57. Kumar D, Wingate D, Ruckebusch Y. Circadian variation in the propagation velocity of the migrating motor complex. Gastroenterology 1986; 91:926-930.
58. Wilson CG, O’Mahony B, Lindsay B. Physiological factors affecting oral drug delivery. In: Swarbrick J, ed. Encyclopaedia of Pharmaceutical Technology. New York: Marcel Dekker, 2002:2214-2222.
59. Degen LP, Phillips SF. Variability of gastrointestinal transit in healthy women and men. Gut 1996; 39:299-305.
60. Bennink R, Peeters M, Van den Maegdenbergh V, Geypens B, Rutgeerts P, De Roo M, Mortelmans L. Evaluation of smallbowel transit for solid and liquid test meal in healthy men and women. Eur J Nucl Med 1999; 26:1560-1566.
61. Graff J, Brinch K, Madsen JL. Gastrointestinal mean transit times in young and middle-aged healthy subjects. Clin Physiol 2001; 21:253-259.
62. Mearadji B, Penning C, Vu MK, van der Schaar PJ, van Peterson AS, Kamerling IMC, Masclee AAM. Influence of gender on proximal gastric motor and sensory function. Am J Gastroenterol 2001; 96:2066-2073.
63. Hutson WR, Roehrkasse RL, Wald A. Influence of gender and menopause on gastric emptying and motility. Gastroenterology 1989; 96:11-17.
64. Wald A, Thiel DHV, Hoechstetter L, Gavaler JS, Egler KM, Verm R, Scott L, Lester R. Gastrointestinal transit: the effect of the menstrual cycle. Gastroenterology 1981; 80:1497-1500.
65. Gill RC, Murphy PD, Hooper HR, Bowes KL, Kingma YJ. Effect of the menstrual cycle on gastric emptying. Digestion 1987; 36:168-174.
66. Horowitz M, Maddern GJ, Chatterton BE, Collins PJ, Petrucco OM, Seamark R, Shearman DJ. The normal menstrual cycle has no effect on gastric emptying. Br J Obstet Gynaecol 1985; 92:743-746.
67. O’Mahony D, O’Leary P, Quigley EM. Aging and intestinal motility: A review of factors that affect intestinal motility in the aged. Drugs Aging 2002; 19:515-527.